Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schaaf

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
PLOS Global Public Health|July 5, 2024
Holistic acceptability of an adult levofloxacin formulation in children and adolescents on a tuberculosis preventive treatment trialSusan E Purchase, Dillon T Wademan, Nosibusiso L Tshetu, et al.
Journal of the International AIDS Society|December 4, 2012
Minimizing the risk of non-vertical, non-sexual HIV infection in children--beyond mother to child transmissionMark F Cotton, Barend J Marais, Monique I Andersson, et al.
Plos Medicine|May 1, 2019
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studiesAnthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant TuberculosisAnthony J Garcia-Prats, Heather R Draper, Heather Finlayson, et al.
The Journal of Antimicrobial Chemotherapy|August 19, 2023
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young childrenLouvina E van der Laan, Anneke C Hesseling, H Simon Schaaf, et al.
The Pediatric Infectious Disease Journal|December 15, 2018
Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant TuberculosisSusan E Purchase, Anthony J Garcia-Prats, Petra De Koker, et al.
The Pediatric Infectious Disease Journal|March 14, 2012
Impact of drug resistance on clinical outcome in children with tuberculous meningitisJames A Seddon, Douwe H Visser, Margaux Bartens, et al.
The Pediatric Infectious Disease Journal|March 22, 2018
Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover TrialAnthony J Garcia-Prats, Penelope C Rose, Heather R Draper, et al.
American Journal of Respiratory and Critical Care Medicine|January 27, 2015
Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden settingAnna M Mandalakas, H Lester Kirchner, Gerhard Walzl, et al.
Plos One|May 19, 2025
Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South AfricaAbenathi Mcinziba, Dillon T Wademan, Klassina Zimri, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
PLOS Global Public Health|July 5, 2024
Holistic acceptability of an adult levofloxacin formulation in children and adolescents on a tuberculosis preventive treatment trialSusan E Purchase, Dillon T Wademan, Nosibusiso L Tshetu, et al.
Journal of the International AIDS Society|December 4, 2012
Minimizing the risk of non-vertical, non-sexual HIV infection in children--beyond mother to child transmissionMark F Cotton, Barend J Marais, Monique I Andersson, et al.
Plos Medicine|May 1, 2019
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studiesAnthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant TuberculosisAnthony J Garcia-Prats, Heather R Draper, Heather Finlayson, et al.
The Journal of Antimicrobial Chemotherapy|August 19, 2023
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young childrenLouvina E van der Laan, Anneke C Hesseling, H Simon Schaaf, et al.
The Pediatric Infectious Disease Journal|December 15, 2018
Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant TuberculosisSusan E Purchase, Anthony J Garcia-Prats, Petra De Koker, et al.
The Pediatric Infectious Disease Journal|March 14, 2012
Impact of drug resistance on clinical outcome in children with tuberculous meningitisJames A Seddon, Douwe H Visser, Margaux Bartens, et al.
The Pediatric Infectious Disease Journal|March 22, 2018
Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover TrialAnthony J Garcia-Prats, Penelope C Rose, Heather R Draper, et al.
American Journal of Respiratory and Critical Care Medicine|January 27, 2015
Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden settingAnna M Mandalakas, H Lester Kirchner, Gerhard Walzl, et al.
Plos One|May 19, 2025
Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South AfricaAbenathi Mcinziba, Dillon T Wademan, Klassina Zimri, et al.
Pageof 18